4-methylsulfanylbenzaldehyde

We are 4-methylsulfanylbenzaldehyde CAS:3446-89-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-methylsulfanylbenzaldehyde
CAS.NO:3446-89-7
Synonyms:4-methylsulfanylbenzaldehyde
4-(Methylthio)benzaldehyde
4-Methylmercaptobenzaldehyde
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 267.0±23.0 °C at 760 mmHg
Melting Point 6 °C
Molecular Formula C8H8OS
Molecular Weight 152.214
Flash Point 133.3±8.3 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.578
 
Specification:
Appearance:Colorless to light yellow oily liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Etoricoxib(CAS:202409-33-4).

4-methylsulfanylbenzaldehyde


Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.Ácido 2-clorofenilborónico CAS:3900-89-8 By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.N,N'-bis(4-bromophenyl)-N,N'-bis(4-methylphenyl)-[1,1'-Biphenyl]-4,4'-diamine CAS:195730-47-3 Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.6-Carboxy-4-methyl-2-propylbenzimidazole CAS:152628-03-0 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.

Related Products
Product Name
Optical Brightening Agent AES-X View Details
4-chloro-1,1-dimethoxybutane View Details
CAS:85509-19-9 Flusilazole View Details
TRIMETHOXY[2-(7-OXABICYCLO[4.1.0]HEPT-3-YL)ETHYL]SILANE Cas:3388-04-3 manufacturer MEGLUMINE Cas:6284-40-8 manufacturer Oxetan-3-yl 4-methylbenzenesulfonate Cas:26272-83-3 manufacturer Methyl 3-carbamimidamido-4-methylbenzoate nitrate (1:1) manufacturer N(α)-t-butoxycarbonyl-L-leucine manufacturer